THOUSAND OAKS, Calif.--Jan. 15, 2002--Amgen (Nasdaq:AMGN) today announced that it will report fourth-quarter and full-year 2001 financial results on Wednesday, January 23, 2002, after the financial markets close. The announcement will be followed by a conference call at 1:30 PM (PST) with the investment community, featuring Kevin Sharer, Chairman and CEO and other members of Amgen's senior management.
Live audio of the conference call will be simultaneously broadcast over the Internet and will be available to members of the news media, investors and the general public. The conference call is expected to last approximately one hour.
This event can be accessed by going to Amgen's website, www.amgen.com, and clicking on Investor Center, then on Amgen Events. The event will be archived and available for replay for 72 hours after the event.
Amgen is a global biotechnology company that discovers, develops, manufactures and markets cost-effective human therapeutics based on advances in cellular and molecular biology.
EDITOR'S NOTE: An electronic version of this news release may be accessed via our web site at www.amgen.com. Visit the Corporate Center and click on Amgen News. Journalists and media representatives may sign up to receive all news releases electronically at time of announcement by filling out a short form in the Amgen News section of the web site.
|CONTACT:||Amgen, Thousand Oaks|
|Jeff Richardson, 805/447-3227 (media)|
|Cary Rosansky, 805/447-4634 (investors)|